696 Brentuximab vedotin, a CD30-directed antibody-drug conjugate, selectively depletes activated Tregs in vitro and in vivo

• Shyra Gardai,
• Bryan Grogan,
• Reice James,
• Michelle Ulrich,
• Ryan Heiser

Affiliations

Shyra Gardai

Seattle Genetics, Inc., Bothell, WA, USA

Bryan Grogan

Seattle Genetics, Inc., Bothell, WA, USA

Reice James

Seattle Genetics, Inc., Bothell, WA, USA

Michelle Ulrich

Seattle Genetics, Inc., Bothell, WA, USA

Ryan Heiser

Seattle Genetics, Inc., Bothell, WA, USA